Medicine and Dentistry
Adult
14%
Adverse Event
11%
Age
34%
Aminolevulinic Acid
26%
Analysis
5%
Arm
17%
Brain Tumor
5%
Cancer Surgery
5%
Cancer Therapy
10%
Chemoradiotherapy
22%
Clotiazepam
8%
Combination Therapy
38%
Combined Therapy
5%
Consent
5%
Cytoreductive Surgery
17%
Diagnosis
30%
Follow up
22%
Ganglioglioma
40%
Glioblastoma
100%
Hazard Ratio
5%
Hemoglobin
8%
Incidence
9%
Karnofsky Performance Status
5%
Male
14%
Morbidity
5%
Mortality
15%
Mortality Rate
5%
Neoplasm
22%
Neuro-Oncology
39%
Oncology
5%
Overall Survival
32%
Patient
99%
Patient Registration
5%
Patient Registry
7%
Physician
11%
Porphyrin
8%
Precursor
8%
Progression Free Survival
14%
Proportional Hazards Model
5%
Quality of Life
11%
Recurrent Disease
23%
Sex
5%
Skull
29%
Steroid
5%
Surgery
75%
Survival
38%
Therapeutic Procedure
49%
Toxicity
17%
Tumor Treating Fields
35%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Aminolevulinic Acid
26%
Brain Tumor
5%
Clotiazepam
8%
Comorbidity
5%
Death
5%
Glioblastoma
100%
Glioma
40%
Hemoglobin
8%
Incidence
9%
Morbidity
5%
Mortality
15%
Mortality Rate
5%
Neoplasm
22%
Overall Survival
32%
Progression Free Survival
14%
Recurrent Disease
23%
Steroids
5%
Study Design
17%
Survival
38%
Symptom
11%
Toxicity
17%
Nursing and Health Professions
Brain Tumor
5%
Comorbidity
5%
Confidence Interval
5%
Data Base
12%
Death
5%
Diagnosis
30%
Follow up
10%
Glioblastoma
35%
Glioma
40%
Household
20%
Medical Record
5%
Mortality
15%
Mortality Rate
5%
Patient
35%
Proportional Hazards Model
5%
Surgery
5%
Survival
25%
Symptom
11%
Validity
12%
